In this exclusive interview for World Hepatitis Day with Drug Target Review, Professor Ziv Ben Ari from the Sheba Medical Center discusses recent progress towards hepatitis treatment.

In this webinar, an assay strategy to assess transport-mediated drug interactions that complies with regulations will be examined.

Using computational methods, researchers analysed the most popular CRISPR library designed for human cells and found 3,300 targeted spots that show strong toxic effects.

An in-silico reaction screening strategy could produce compounds potentially useful for novel drug development.

The researchers identified key molecular differences between triple-negative breast cancer cells that cling to an initial tumour and those that venture off to form distant tumours.